Webinar on Demand, Professor Sabaté - Effect of Bifidobacterium longum 35624® on Irritable Bowel Syndrome severity and quality of life. Results of the Floravie observational study

This is the first module in our Probiotics e-learning series. By completing this module, you should be able to, Understand key terms and concepts in relation to probiotics, including the gut-brain-axis, microbiota, microbiome, probiotics and genetic sequencing, Understand the regulatory framework relating to probiotics.

This is the second module in this Probiotics e-learning series.​ By completing this module, you should be able to,​ (1) Understand the presentation, prevalence and impact of irritable bowel syndrome (IBS), (2) Understand the psychological components of IBS as a disorder of the gut-brain-axis​, (3) Understand the role of the gut microbiota in IBS, (4) Understand the potential role of certain probiotics in the management of IBS, with recognition of key clinical guidelines​.

This is the third module in this Probiotics e-learning series.​ ​By completing this module, you should be able to, - (1) Understand the strain-specific clinical evidence for the use of a probiotic in IBS, (2) Understand the strain-specific real-world evidence for the use of a probiotic in IBS, (3) Understand the outcomes of the latest research into the use of a dual strain probiotic in IBS, (4) Understand the evidence of strain safety and viability.

This is the fourth module in this Probiotics e-learning series.​ By completing this module, you should be able to,​Understand the factors which should be considered when selecting an appropriate probiotic supplement for patients, including, Strain specificity,  caution with combinations of strains, evidence base, dosage, promoting compliance, suitability, adjuvant therapies and quality assurance.

This is the fifth module in this Probiotics e-learning series.​ By completing this module, users should be able to, (1) Understand the potential application of probiotics in emerging areas of health and disease including stress, sports, inflammatory conditions and immune health, (2) Understand the approach to developing probiotic technology.

Dr Choudhary will provide an overview of irritable bowel syndrome (IBS), with a focus upon the role of specific strains of probiotics as part of the management of symptoms, before reflecting on her own clinical practice to share top tips for pharmacists to consider when discussing and recommending probiotic products to individuals.

In this webinar, Laurence Stoll, Medical marketing Novonesis consumer health, discusses the role of the immune system and how factors like probiotics can influence its function, she is also sharing clinical evidence on how L. Casei 431® helps modulate the immune response.

In this webinar, Laurence Stoll, Medical marketing Novonesis consumer health, explains the impact of antibiotics on the gut, incidence of antibiotic associated diarrhoea, and the clinical evidence supporting the use of probiotics for AAD management for the strains Bifidobacterium animalis, BB-12® & Lactobacillus acidophilus, LA-5®.

This reflective article, and accompanying reflective questions, aim to help healthcare professionals develop their understanding in the field of irritable bowel syndrome (IBS), gut health and probiotics. Registered dietitian Dr. Sarah Schenker provides an overview of the clinical evidence and guidelines for the management of IBS and its psychological comorbidities, and how this informed the dietetic management approach she chose for an individual on her caseload with diarrhoea predominant IBS. Sarah reflects on her learnings from the approach taken and how she might apply this in her future management of similar individuals.

This reflective article, and accompanying reflective questions, aim to help healthcare professionals develop their understanding in the field of irritable bowel syndrome (IBS), gut health and probiotics. Registered dietitian Dr. Sarah Schenker provides an overview of the clinical evidence and guidelines for the management of IBS and its psychological comorbidities, and how this informed the dietetic management approach she chose for an individual on her caseload with diarrhoea predominant IBS. Sarah reflects on her learnings from the approach taken and how she might apply this in her future management of similar individuals.

In this short webinar, registered dietitian Dr Fiona Kinnear (PhD) delivers a brief overview of the role of the gut microbiota and probiotics in the management of the gastrointestinal and psychosocial symptoms of irritable bowel syndrome (IBS), before detailing the results of a research study which investigated the real world experiences of individuals with IBS who received a dual strain Bifidobacterium longum probiotic. Fiona also discusses the findings in relation to previous clinical trials and implications for the clinical management of IBS symptoms. A reflective learning guide is available for you to complete after watching.

In this webinar on demand, Dr Makinen delivers an overview of the gut microbiota and probiotics in health, disease and sports performance, and guides you through the latest research on strain-specific probiotics in athletes. A reflective learning guide is available for you to complete after watching.

In this short webinar, registered dietitian Katy Sorensen delivers a brief introduction to the proposed relationship between the gut microbiota, the stress response and probiotics in the management of the symptoms of irritable bowel syndrome (IBS), before detailing the results of an interventional research study which explored the effects of a dual strain Bifidobacterium longum probiotic on psychological status, gastrointestinal symptoms, and biomarkers of stress and inflammation in females with IBS. Katy also discusses the findings in relation to our understanding of the relationships between psychological and visceral symptoms and inflammation in IBS. A reflective learning guide is available for you to complete after watching.

In this webinar on demand, registered dietitian Lorraine Cooney discusses the associations between diet quality (in particular, the importance of diverse plant-based diets), the gut microbiome, and the risk of Coronavirus Disease 2019 (COVID-19) and other conditions. Lorraine reviews up to date clinical evidence to provide dietary and lifestyle interventions to support gut health and offers tips to support patients in making these changes. A reflective learning guide is available for you to complete after watching.

In this webinar, registered dietitian Priya Tew recaps the definition and diagnostic criteria of irritable bowel syndrome (IBS), and discusses the relationship between the gut microbiome, mental health and IBS. Priya also explains the clinical evidence for the use of strain-specific probiotics, and the implications of this for the management of IBS and its psychological comorbidities. A reflective learning guide is available for you to complete after watching.

In this webinar on demand recorded for the 2021 British Society of Gastroenterology Annual Meeting, Professor Eamonn Quigley provides an update on definitions and pathophysiology associated with functional gastrointestinal disorders (FGIDs), and the latest research on probiotics for brain and gut health. A reflective learning guide is available for you to complete after watching. 

In this webinar, Professor Emmanuel summarises the multi-factorial pathophysiology of irritable bowel syndrome (IBS) and discusses the potential role of probiotics as part of the management of IBS symptoms, including an overview the clinical evidence of the Bifidobacterium longum 35624™ probiotic strain. Alongside reflections of his own clinical experience with individuals with IBS, Professor Emmanuel provides practical tips for communicating with individuals regarding their symptoms and management approaches in the pharmacy setting. A reflective learning guide is available for you to complete after watching.

In this webinar on demand, Professor Quigley delivers a summary of the role of the gut microbiota and probiotics in the management of the symptoms of irritable bowel syndrome (IBS) and an overview of probiotic modes of action. The latest research is discussed, with a focus upon the specific modes of action of the Bifidobacterium longum 35624® probiotic strain. A reflective learning guide is available for you to complete after watching.

In this webinar on demand, Professor O’Mahony talks about the role of gut microbes in immune and intestinal health in patients with COVID-19, how these microbes may be predictors of responses to COVID-19, and discusses the consideration of practical approaches to modulate the gut microbiome response in the management of COVID-19. A reflective learning guide is available for you to complete after watching.